Expertise in
6
conditions

Nicolas Terzi

CHU De Caen
Caen, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
6
conditions
CHU De Caen
Caen, FR 
OverviewLocationsClinical Research

Overview

Nicolas Terzi practices in Caen, France. Mr. Terzi is highly rated in 6 conditions, according to our data. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Pneumonia, COVID-19, and Severe Acute Respiratory Syndrome (SARS).

His clinical research consists of co-authoring 164 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

CHU de Caen
Caen, 14000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
Enrollment Status: Recruiting
Publish Date: August 05, 2025
Intervention Type: Drug
Study Drug: Levosimendan
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
Enrollment Status: Completed
Publish Date: September 23, 2024
Intervention Type: Biological, Drug
Study Drugs: Otilimab, Standard of Care
Study Phase: Phase 2
Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Other, Drug
Study Drugs: Remdesivir, Lopinavir, Ritonavir, Interferon Beta-1A, Hydroxychloroquine, AZD7442
Study Phase: Phase 3
COVID-19: Prospective Follow-up of Pulmonary Function, Sleep Disorders, Quality of Life and Post-traumatic Stress
COVID-19: Prospective Follow-up of Pulmonary Function, Sleep Disorders, Quality of Life and Post-traumatic Stress
Enrollment Status: Active_not_recruiting
Publish Date: July 26, 2024
Intervention Type: Other
Consumption of New Psychoactive Substances in Intoxicated Patients During the Winter Activities
Consumption of New Psychoactive Substances in Intoxicated Patients During the Winter Activities
Enrollment Status: Completed
Publish Date: November 29, 2023
Intervention Type: Other
Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia
Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia
Enrollment Status: Completed
Publish Date: January 10, 2023
Intervention Type: Drug
Study Drug: Hydrocortisone
Study Phase: Phase 3
Detection of Right Ventricular Dysfunction by 2D Strain During Acute Respiratory Distress Syndrom (ARDS)
Detection of Right Ventricular Dysfunction by 2D Strain During Acute Respiratory Distress Syndrom (ARDS)
Enrollment Status: Completed
Publish Date: November 08, 2022
Cardiac Arrest Incidence and Outcome Among Patient With COVID-19 Pneumonia in French ICUs
Cardiac Arrest Incidence and Outcome Among Patient With COVID-19 Pneumonia in French ICUs
Enrollment Status: Completed
Publish Date: October 13, 2022
Intervention Type: Other
Evaluation of Prone Position in Conscious Patients on Nasal High-flow Oxygen Therapy for COVID-19 Disease Induced Acute Respiratory Distress Syndrome
Evaluation of Prone Position in Conscious Patients on Nasal High-flow Oxygen Therapy for COVID-19 Disease Induced Acute Respiratory Distress Syndrome
Enrollment Status: Completed
Publish Date: April 19, 2021
Intervention Type: Other
Study Phase: Not Applicable
Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU
Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU
Enrollment Status: Completed
Publish Date: March 30, 2021
Expiratory Fow Assessment in ARDS Patients
Expiratory Fow Assessment in ARDS Patients
Enrollment Status: Completed
Publish Date: August 14, 2019
Intervention Type: Other
Study Phase: Not Applicable
View 10 Less Clinical Trials

164 Total Publications

Outcomes of Critically Ill Adult Patients With Acute Encephalitis.
Outcomes of Critically Ill Adult Patients With Acute Encephalitis.
Journal: JAMA network open
Published: September 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Terzi's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile